Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization programs and human immunodeficiency virus.

J R La Montagne1

  • 1Microbiology and Infectious Diseases Program, National Institute of Allergy and Infectious Disease, Bethesda, Maryland 20892.

Reviews of Infectious Diseases
|May 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biotechnology and research: promise and problems.

Lancet (London, England)·2001
Same author

Adult immunization: principles and practice.

Advances in internal medicine·1999
Same author

RSV pneumonia, a community-acquired infection in adults.

Lancet (London, England)·1997
Same author

The United States research strategy on pertussis.

Developments in biological standardization·1997
Same author

Fungal infections: a growing threat.

Public health reports (Washington, D.C. : 1974)·1996
Same author

Public health implications of emerging vaccine technologies.

Pharmaceutical biotechnology·1995

Human immunodeficiency virus (HIV) infection can impair vaccine effectiveness and potentially accelerate AIDS progression. Immunization programs must consider altered vaccine responses and safety in HIV-positive individuals.

Area of Science:

  • Immunology
  • Virology
  • Public Health

Background:

  • Human immunodeficiency virus (HIV) infection leads to progressive immunosuppression, affecting the immune system's ability to respond to pathogens.
  • HIV can remain latent for years, complicating diagnosis and management, and potentially impacting vaccine efficacy.
  • The interaction between HIV, the immune system, and vaccine responses requires careful consideration for public health strategies.

Purpose of the Study:

  • To explore the implications of HIV emergence on immunization programs.
  • To analyze how HIV infection affects vaccine efficacy and safety.
  • To discuss challenges and future prospects for HIV vaccines.

Main Methods:

  • Review of existing literature on HIV and immunology.

Related Experiment Videos

  • Analysis of the impact of immunosuppression on vaccine-induced immune responses.
  • Consideration of safety profiles of standard vaccines in HIV-positive individuals.

    • Main Results:

    • Vaccines may elicit suboptimal protective responses in HIV-infected individuals due to immunosuppression.
    • Immune system stimulation could potentially accelerate HIV replication and AIDS progression.
    • Altered vaccine safety profiles in HIV-positive individuals need to be evaluated.

    Conclusions:

    • HIV infection presents unique challenges for immunization programs, including reduced vaccine efficacy and potential safety concerns.
    • Strategies to prevent accidental HIV transmission during mass vaccination campaigns are crucial.
    • Further research into the development and testing of effective HIV vaccines is essential.